Upidosin
Alternative Names: REC 152739; REC 22009; SB 216469Latest Information Update: 20 Aug 1999
At a glance
- Originator Recordati
- Class
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia
Most Recent Events
- 20 Aug 1999 Discontinued-II for Benign prostatic hyperplasia in Belgium (Unknown route)
- 20 Aug 1999 Discontinued-II for Benign prostatic hyperplasia in Israel (Unknown route)
- 10 Feb 1999 REC 152739 is now called upidosin